technogate.co.in

What It Is

PharmaHub is a cloud-based research and commercial decision-making platform for the pharmaceutical industry. Its core proposition is to bring fragmented public regulatory and product data into a single workspace, helping companies move from product screening to revenue management. According to the website, it aims to reduce the manual search time involved in drug R&D, product planning, competitor analysis, and operational planning, while supporting sales and operations through industry best-practice workflows.

Core Features and Data Dimensions

The platform focuses heavily on FDA-related public data, including FDA-approved drug lists, FDA warning letters, import alerts, Orange Book patents and exclusivity periods, ANDA/NDA information, DMF holders, API supply, RLD, TE Code, orphan drugs, DEA status, drug classifications, and more. The site also shows functions such as product screening, applicant search, adding/removing fields, and adding filter criteria. These features make it suitable for generic drug opportunity screening, evaluating supply sources, and conducting preliminary regulatory risk checks.

Collaboration, Deployment, and Integrations

The main content explicitly describes PharmaHub as a cloud-based platform, indicating that it is primarily delivered as SaaS. The page includes an “Add Secondary User” form, suggesting support for adding secondary users, but it does not disclose role-based permissions, team workspaces, audit logs, or approval workflows. Key details such as third-party integrations, APIs, developer documentation, security compliance, and data update frequency are not explained in the captured content, so these should be confirmed carefully before procurement.

Pricing and Trial

The official website does not disclose plans, pricing, seat counts, or contract models. It only provides a demo video and a free demo request entry point. As a result, it is not possible to assess its actual cost-effectiveness from public information. For enterprise procurement, it is advisable to ask during the demo stage about data coverage, refresh frequency, export limits, number of users, service support, and renewal terms.

Pros, Cons, and Who It’s For

Its strengths are its strong industry focus and field design that closely matches use cases in drug R&D, portfolio management, business development, and supply chain evaluation. The founding team also appears to have pharmaceutical business experience, and the product approach is relatively pragmatic. The main drawbacks are the limited public information and the lack of transparency around pricing, security, APIs, and integration capabilities. It is best suited for pharmaceutical BD, portfolio management, generic drug planning, regulatory intelligence, and commercial operations teams looking to improve the efficiency of early-stage research.

Access from China and Alternatives

Access from mainland China is unknown, and payment methods or Chinese localization are not disclosed. If local Chinese drug regulatory, medical insurance, procurement, or Chinese-language data is required, users may also evaluate 药智数据 and 医药魔方. For global pharmaceutical intelligence, alternatives to compare include Clarivate Cortellis, Citeline, Evaluate Pharma, and GlobalData.